nonarrhythmogenic drug
nonarrhythmogenic effect
nonarrhythmogenic medication
nonarrhythmogenic properties
nonarrhythmogenic agent
nonarrhythmogenic therapy
nonarrhythmogenic treatment
nonarrhythmogenic compound
nonarrhythmogenic substance
nonarrhythmogenic solution
the new drug is nonarrhythmogenic and safe for patients with heart disease.
researchers discovered a nonarrhythmogenic compound that lowers blood pressure.
this therapy is nonarrhythmogenic, making it suitable for long‑term use.
the study highlighted the nonarrhythmogenic effect of the natural supplement.
clinicians prefer nonarrhythmogenic agents when treating arrhythmia‑prone patients.
the nonarrhythmogenic property of the medication reduces risk of sudden cardiac death.
in clinical trials, the nonarrhythmogenic drug showed no pro‑arrhythmic side effects.
the new agent is marketed as a nonarrhythmogenic alternative to standard beta‑blockers.
the mechanism by which the compound is nonarrhythmogenic remains under investigation.
physicians evaluated the nonarrhythmogenic potential of the herbal extract.
the drug’s nonarrhythmogenic profile makes it a candidate for pediatric use.
our findings support the hypothesis that the molecule is nonarrhythmogenic.
nonarrhythmogenic drug
nonarrhythmogenic effect
nonarrhythmogenic medication
nonarrhythmogenic properties
nonarrhythmogenic agent
nonarrhythmogenic therapy
nonarrhythmogenic treatment
nonarrhythmogenic compound
nonarrhythmogenic substance
nonarrhythmogenic solution
the new drug is nonarrhythmogenic and safe for patients with heart disease.
researchers discovered a nonarrhythmogenic compound that lowers blood pressure.
this therapy is nonarrhythmogenic, making it suitable for long‑term use.
the study highlighted the nonarrhythmogenic effect of the natural supplement.
clinicians prefer nonarrhythmogenic agents when treating arrhythmia‑prone patients.
the nonarrhythmogenic property of the medication reduces risk of sudden cardiac death.
in clinical trials, the nonarrhythmogenic drug showed no pro‑arrhythmic side effects.
the new agent is marketed as a nonarrhythmogenic alternative to standard beta‑blockers.
the mechanism by which the compound is nonarrhythmogenic remains under investigation.
physicians evaluated the nonarrhythmogenic potential of the herbal extract.
the drug’s nonarrhythmogenic profile makes it a candidate for pediatric use.
our findings support the hypothesis that the molecule is nonarrhythmogenic.
Galugarin ang madalas na hinahanap na bokabularyo
Gusto mo bang matutunan ang bokabularyo nang mas episyente? I-download ang DictoGo app at mag-enjoy sa mas maraming features para sa pag-memorize at pag-review ng bokabularyo!
I-download ang DictoGo Ngayon